GSPQX
Price
$20.44
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
KNGCX
Price
$11.70
Change
+$0.06 (+0.52%)
Updated
Aug 21 closing price
Net Assets
48.67M
Interact to see
Advertisement

GSPQX vs KNGCX

GSPQX vs KNGCX Comparison Chart in %
View a ticker or compare two or three
VS
GSPQX vs. KNGCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPQX is a StrongBuy and KNGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSPQX has more cash in the bank: 3.94B vs. KNGCX (48.7M). KNGCX pays higher dividends than GSPQX: KNGCX (0.76) vs GSPQX (0.06). GSPQX was incepted earlier than KNGCX: GSPQX (21 years) vs KNGCX (9 years). KNGCX (2.34) is less costly to investors than GSPQX (1.86). KNGCX is a more actively managed with annual turnover of: 422.70 vs. GSPQX (29.00). GSPQX (1000) and KNGCX (1000) have matching initial minimum investment requirements. GSPQX annual gain was more profitable for investors over the last year : 13.89 vs. KNGCX (0.57). GSPQX return over 5 years is better than : 27.70 vs. KNGCX (-13.52).
GSPQXKNGCXGSPQX / KNGCX
Total Expense Ratio1.751.9590%
Annual Report Gross Expense Ratio1.862.3479%
Fund Existence21 years9 years-
Gain YTD12.6512.529500%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B48.7M8,086%
Annual Yield % from dividends0.060.768%
Returns for 1 year13.890.572,425%
Returns for 3 years39.77-6.95-572%
Returns for 5 years27.70-13.52-205%
Returns for 10 years75.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
PMAX1.260.02
+1.61%
Powell Max Limited
BWXT156.780.34
+0.22%
BWX Technologies
SUPN45.85-1.60
-3.37%
Supernus Pharmaceuticals